<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2003 (6) TMI 390 - COMMISSIONER OF CENTRAL EXCISE &amp; CUSTOMS (APPEALS)</title>
    <link>https://www.taxtmi.com/caselaws?id=109560</link>
    <description>A corporate logo or house mark printed on pharmaceutical products does not, by itself, constitute a brand name for excise classification unless it identifies a trade relationship linking the mark to the medicines. Here, the mark &quot;rp Rhone Poulenc&quot; was registered, but it was used uniformly as a house mark on products manufactured for the company and did not indicate that the goods were branded medicines. On that basis, the products were treated as generic medicines under Chapter sub-heading 3003.20 of the Central Excise Tariff Act, 1985, and not as patent and proprietary medicaments.</description>
    <language>en-us</language>
    <pubDate>Mon, 30 Jun 2003 00:00:00 +0530</pubDate>
    <lastBuildDate>Fri, 18 May 2012 16:10:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=146577" rel="self" type="application/rss+xml"/>
    <item>
      <title>2003 (6) TMI 390 - COMMISSIONER OF CENTRAL EXCISE &amp; CUSTOMS (APPEALS)</title>
      <link>https://www.taxtmi.com/caselaws?id=109560</link>
      <description>A corporate logo or house mark printed on pharmaceutical products does not, by itself, constitute a brand name for excise classification unless it identifies a trade relationship linking the mark to the medicines. Here, the mark &quot;rp Rhone Poulenc&quot; was registered, but it was used uniformly as a house mark on products manufactured for the company and did not indicate that the goods were branded medicines. On that basis, the products were treated as generic medicines under Chapter sub-heading 3003.20 of the Central Excise Tariff Act, 1985, and not as patent and proprietary medicaments.</description>
      <category>Case-Laws</category>
      <law>Central Excise</law>
      <pubDate>Mon, 30 Jun 2003 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=109560</guid>
    </item>
  </channel>
</rss>